Use of antifungal drugs in hematology

Marcio Nucci1

  • 1Universidade Federal do Rio de Janeiro - UFRJ, Rio de Janeiro, RJ, Brazil.

Insights

Hematology patients often develop invasive fungal disease. This review covers antifungal agents, their uses in prophylaxis and treatment, and key properties for hematologists.

Area of Science:

  • Hematology
  • Mycology
  • Pharmacology

Background:

  • Invasive fungal disease is a significant complication in patients with hematological conditions.
  • Antifungal agents are integral to managing these patients, used for prophylaxis, empiric, preemptive, or therapeutic purposes.
  • Hematologists require comprehensive knowledge of fungal disease epidemiology, diagnostics, and antifungal pharmacodynamics.

Purpose of the Study:

  • To review the principal antifungal agents used in hematological patients.
  • To discuss the clinical scenarios necessitating antifungal use in this population.
  • To provide hematologists with essential information on antifungal strategies.

Main Methods:

  • Literature review of antifungal agents and their application in hematology.
  • Discussion of epidemiological data and diagnostic approaches for invasive fungal disease.
  • Analysis of pharmacologic properties and clinical usage patterns of antifungals.

Main Results:

  • Key antifungal agents and their specific roles in hematological care are detailed.
  • Clinical contexts for antifungal prophylaxis, empiric, preemptive, and treatment strategies are outlined.
  • Pharmacological profiles and practical considerations for antifungal selection are presented.

Conclusions:

  • Effective management of invasive fungal disease in hematology patients relies on understanding antifungal agents and their appropriate application.
  • Hematologists must be well-versed in antifungal pharmacology and clinical guidelines to optimize patient outcomes.
  • This review serves as a guide to antifungal use in hematological contexts.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...